Spider-venom Peptides that Target the Human NaV1.7 channel: Potential Analgesics for the Treatment of Chronic Pain

被引：0
|
作者：
Klint, Julie [1 ]
Anangi, Raveendra [1 ]
Mobli, Mehdi [1 ]
Knapp, Oliver [2 ]
Adams, David J. [2 ]
King, Glenn F. [1 ]
机构：
[1] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia
[2] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia
来源：
TOXICON | 2012年 / 60卷 / 02期
关键词：
spider-venom peptides; NaV1.7; therapeutics; analgesics; structure-function relationships; pharmacophore; drug development;
D O I：
10.1016/j.toxicon.2012.04.032
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
31
引用
收藏
页码：110 / 111
页数：2
相关论文
共 33 条
  • [31] The pain target NaV1.7 is expressed late during human iPS cell differentiation into sensory neurons as determined in high-resolution imaging
    Liu, Yi
    Balaji, Rachna
    de Toledo, Marcelo A. Szymanski
    Ernst, Sabrina
    Hautvast, Petra
    Kesdogan, Aylin B.
    Koerner, Jannis
    Zenke, Martin
    Neureiter, Anika
    Lampert, Angelika
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2024, 476 (06): : 975 - 992
  • [32] Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7
    Henriques, Sonia Troeira
    Deplazes, Evelyne
    Lawrence, Nicole
    Cheneval, Olivier
    Chaousis, Stephanie
    Inserra, Marco
    Thongyoo, Panumart
    King, Glenn F.
    Mark, Alan E.
    Vetter, Irina
    Craik, David J.
    Schroeder, Christina I.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (33) : 17049 - 17065
  • [33] Cilnidipine, a Novel N-Type Specific Calcium Channel Antagonist, Has Potent Activity at the Nav1.7 Sodium Channel, Which May Have Implications for Treatment of Certain Neuropathic Pain Conditions
    Sternlicht, Andrew
    [J]. NEUROLOGY, 2023, 100 (17)
1234